Synergy CHC (SNYR) Insider File: 150K-Share Option to CFO, 09/18/2025
Rhea-AI Filing Summary
Jaime Fickett, identified as Chief Financial Officer of Synergy CHC Corp. (SNYR), reported a grant of a stock option on 09/18/2025. The option covers 150,000 shares of common stock with an exercise price of $2.38 per share and an expiration date shown as 09/18/2030. The filing states the full award is held directly by the reporting person following the transaction. The option vests one-third on the first anniversary of the grant and the remaining two-thirds in equal monthly installments over the subsequent 24 months, subject to continued service. The form was signed by an attorney-in-fact on 09/22/2025.
Positive
- Time-based vesting aligns the CFO's incentives with multi-year shareholder value creation
- Disclosure filed promptly with a signature by attorney-in-fact, meeting reporting requirements
Negative
- Potential dilution of 150,000 shares if the option is exercised
- No performance-based conditions are disclosed; vesting is solely time-based
Insights
TL;DR: Routine executive equity award to CFO, standard multi-year vesting and five-year term.
The filing documents a non-derivative equity grant in the form of a stock option for 150,000 shares at a $2.38 exercise price, expiring 09/18/2030. Vesting is time-based: one-third after one year and the remainder monthly over 24 months. For investors, this is a customary retention and incentive tool rather than an immediate cash impact. The award increases potential future dilution if exercised, but the grant itself is a standard corporate governance practice for senior management.
TL;DR: Compensation action aligns CFO incentives with shareholders but creates future dilution if fully exercised.
The reported option is direct beneficial ownership and uses a multi-year vesting schedule tied to continued service, which is consistent with aligning executive performance and retention goals. The five-year contractual life to 09/18/2030 provides a window for potential alignment with long-term value creation. The filing contains clear vesting terms and shows timely disclosure by the issuer, meeting routine Section 16 reporting expectations.
FAQ
What did Jaime Fickett report in the Form 4 for SNYR?
What are the vesting terms of the option reported on Form 4?
Is the reported ownership direct or indirect?
Does the Form 4 show the exercise price and expiration date?
Who signed the Form 4 and when?